Abstract
Vaccines have a distinguished history originating from the demonstration by Jenner in 1796 that cowpox could protect against the development of smallpox. Historically, the objective of vaccination was to provide effective immunity to the target disease, and with the introduction earlier this century of widespread immunisation for diseases such as diphtheria, tetanus, polio, smallpox and pertussis, the occurrence of these diseases has been significantly reduced if not eliminated. However, the acceptance of immunisation programs in the community could have been jeopardised by the rare events which occurred as a result of poor vaccine manufacture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
James, R.W., 1994, Toxicity Testing Strategies for Biotechnology-Derived and High Technology Products, BIRA Journal, 12: 10.
OECD, 1992, The OECD Principles of Good Laboratory Practice, Environment Monograph No.45. Organisation For Economic Co-operation and Development, OCDE/GD(92)32, Paris.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bennet, J.K. (1997). From Scientific Discovery to Clinical Trial: Overcoming the Regulatory Hurdles — A Guide for Academic Researchers. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccine Design. NATO ASI Series, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0062-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0062-3_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0064-7
Online ISBN: 978-1-4899-0062-3
eBook Packages: Springer Book Archive